|
SLC35B4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.165400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.411600E-01 |
| Normal-vs-Stage2 |
1.930150E-02 |
| Normal-vs-Stage3 |
3.344000E-01 |
| Normal-vs-Stage4 |
9.316300E-02 |
| Stage1-vs-Stage2 |
2.835500E-03 |
| Stage1-vs-Stage3 |
8.176000E-01 |
| Stage1-vs-Stage4 |
2.638200E-01 |
| Stage2-vs-Stage3 |
1.704110E-03 |
| Stage2-vs-Stage4 |
9.033300E-04 |
| Stage3-vs-Stage4 |
4.103800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.913600E-01 |
| Normal-vs-AfricanAmerican |
5.759200E-01 |
| Normal-vs-Asian |
2.115200E-01 |
| Caucasian-vs-AfricanAmerican |
2.957200E-01 |
| Caucasian-vs-Asian |
5.045600E-01 |
| AfricanAmerican-vs-Asian |
1.648970E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.864200E-01 |
| Normal-vs-Female |
5.437800E-01 |
| Male-vs-Female |
9.299000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.237600E-01 |
| Normal-vs-Age(41-60Yrs) |
4.457000E-01 |
| Normal-vs-Age(61-80Yrs) |
5.711200E-01 |
| Normal-vs-Age(81-100Yrs) |
6.647400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.173400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.297600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.736000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.014800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.672200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.130200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.651600E-02 |
| Classical-VS-Follicular |
3.217600E-02 |
| Classical-VS-Other |
5.895000E-01 |
| Classical-VS-Normal |
5.451200E-01 |
| Tall-VS-Follicular |
1.778080E-03 |
| Tall-VS-Other |
6.712000E-01 |
| Tall-VS-Normal |
2.080400E-02 |
| Follicular-VS-Other |
2.593400E-01 |
| Follicular-VS-Normal |
1.539000E-01 |
| Other-VS-Normal |
3.488200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.912400E-01 |
| Normal-vs-N1 |
2.952300E-02 |
| N0-vs-N1 |
4.709800E-02 |
|
|
